eFFECTOR Therapeutics (EFTR) Stock Statistics & Valuation Metrics

eFFECTOR Therapeutics has a market cap or net worth of $2.82K. The enterprise value is $52.50.

eFFECTOR Therapeutics has 4,704,409 shares outstanding. The number of shares has decreased by -2.65% in one year.

eFFECTOR Therapeutics’s return on equity (ROE) is 6.18 and return on invested capital (ROIC) is -221.30%.

The current PE Ratio of eFFECTOR Therapeutics is ―. eFFECTOR Therapeutics’s PEG ratio is -0.00658.

In the last 12 months, eFFECTOR Therapeutics had revenue of 0.00 and earned -35.81M in profits. Earnings per share was -16.37.

In the last 12 months, operating cash flow was -29.19M and capital expenditures -84.00K, giving a free cash flow of -29.27M billion.

eFFECTOR Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

eFFECTOR Therapeutics upcoming earnings date is May 13, 2025, Before Open (Confirmed).

eFFECTOR Therapeutics as a current ratio of 0.77, with Debt / Equity ratio of -354.53%

In the past 12 months, eFFECTOR Therapeutics has paid 0.00 in taxes.

eFFECTOR Therapeutics EV to EBITDA ratio is -0.95, with an EV/FCF ratio of -1.05.

eFFECTOR Therapeutics has $25.38M in cash and marketable securities with $20.25M in debt, giving a net cash position of $5.13M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for eFFECTOR Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―